FDA's Approval Process for Abortion Pills Under Threat

A court battle over the abortion drug mifepristone may impact the approval of almost every drug nationwide, warn legal experts and pharmaceutical companies. A federal court ruling in Texas attempted to halt the FDA's approval of mifepristone, which has left the future of the drug uncertain. Experts say the ruling may also have implications for other FDA-approved drugs and threaten the country's entire regulatory structure. The ruling may open up the opportunity for biotech and pharmaceutical companies to target FDA approval of competitors' products to get a competing drug pulled off the market. The case is headed to the U.S. Supreme Court.